Related Experiment Video

Updated: Mar 20, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

13.4K

Therapeutic Prospects of Gene Therapy for Atrial Fibrillation

Melad Farraha1, James J H Chong2, Eddy Kizana2

  • 1Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.

Heart, Lung & Circulation
|June 6, 2016
PubMed

Insights

Gene therapy offers a promising new avenue for treating Atrial Fibrillation (AF), a common heart rhythm disorder. Research is exploring novel gene transfer vectors and strategies to effectively restore normal heart rhythm and control rate.

Area of Science:

  • Cardiology
  • Molecular Medicine
  • Genetics

Background:

  • Atrial Fibrillation (AF) is a prevalent cardiac arrhythmia linked to severe health risks like stroke and death.
  • Current treatments for AF, including medications and catheter ablation, have limitations, necessitating innovative therapeutic approaches.

Purpose of the Study:

  • To review current gene therapy vectors and delivery methods for cardiovascular applications.
  • To evaluate gene therapy strategies for restoring sinus rhythm and controlling ventricular rate in Atrial Fibrillation.

Main Methods:

  • Review of existing literature on gene therapy vectors and their application in cardiovascular diseases.
  • Analysis of identified gene therapy targets and strategies for AF treatment.
  • Discussion of vector delivery methods to the atrium.

Main Results:

  • Advancements in gene transfer vector efficiency and biosafety are enabling cardiovascular applications.
  • Several gene therapy targets and strategies show potential for AF rhythm and rate control.

Conclusions:

  • Gene therapy presents a viable and innovative approach to address the unmet needs in Atrial Fibrillation treatment.
  • Further research into specific gene therapy strategies and delivery systems is warranted for clinical translation in AF.

Keywords:
ArrhythmiaAtrial fibrillationGene therapyHeartViral vector

More Related Videos

A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts13:58

A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts

Published on: September 10, 2018

11.0K
Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

9.6K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.0K
Gene Therapy00:59

Gene Therapy

4.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
540
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
537